Affimed N.V.
AFMD
AFMD: Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.
moreShow AFMD Financials
Recent trades of AFMD by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by AFMD's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on AFMD's company Twitter account
Number of mentions of AFMD in WallStreetBets Daily Discussion
Recent insights relating to AFMD
Recent picks made for AFMD stock on CNBC
ETFs with the largest estimated holdings in AFMD
Flights by private jets registered to AFMD